http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7601352-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4737ef883afc54e0843369b843b4ca5e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
filingDate 2000-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34a06cefbeae9d0c6fd5599a8d01d48e
publicationDate 2009-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7601352-B1
titleOfInvention Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA
abstract Monoclonal antibodies, synthetic and biotechnological derivatives thereof (ScFv or others) are able to recognize the NGF high affinity receptor, TrkA, and act as NGF-antagonist molecules. Pharmacological compositions for therapy, gene therapy, diagnostics of neurological pathologies are also described. Transgenic animal models to study such pathologies are also described.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9783601-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016244529-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10227402-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8148107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011206682-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9738713-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013336964-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9353176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9783602-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11214610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8911734-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8728473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10344083-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884909-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10266588-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10982002-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10093725-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9078878-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8613927-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011014208-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9951128-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9539324-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10457727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8637031-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9718882-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10618974-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10125192-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9067988-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9617334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486401-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11518804-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9505829-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221236-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9365654-B2
priorityDate 1999-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0471205-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9515180-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226818647
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128107971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7071

Total number of triples: 77.